Q3 FY26 Results Presentation
| Stock | MACH7 Technologies Ltd (M7T.ASX) |
|---|---|
| Release Time | 24 Apr 2026, 8:34 a.m. |
| Price Sensitive | Yes |
Mach7 Q3 FY26 Results Presentation
- Contracted Annual Recurring Revenue (CARR) up A$0.3M to A$25.8M
- Q3 FY26 Sales Orders TCV of A$6.0M, up from A$4.8M in Q3 FY25
- Closing Cash of A$18.2M, strong financial position with no debt
Mach7 Technologies Ltd reported its Q3 FY26 results, highlighting a 6% increase in Contracted Annual Recurring Revenue (CARR) to A$25.8M, up from A$25.5M at 31 December 2025. Q3 FY26 Sales Orders TCV was A$6.0M, up from A$4.8M in Q3 FY25. The company maintained a strong financial position with closing cash of A$18.2M and no debt. The results reflect the company's progress in its commercial transformation, with improved customer-aligned product delivery, strengthened discipline across CRM and pricing, and a rebuild of the sales capacity to support future growth. The company also expanded its partner ecosystem, activating 10 partners across four categories, including strategic alliances, regional resellers, clinical workflow integrators, and international partners. Looking ahead, FY26 revenue is expected to be approximately 15% below FY25 due to reduced services and delayed conversion of large capital deals, particularly in the Middle East. However, the company remains positioned for future operating leverage as execution and conversion progress into FY27.
FY26 revenue is expected to be approximately 15% below FY25, reflecting reduced services and delayed conversion of large capital deals, particularly in the Middle East. Operating expenses are now expected to be approximately 10% below FY25 reflecting improved cost control and efficiencies.
Underlying demand remains intact, with a solid pipeline and increasing mix of ARR opportunities. The company is positioned for future operating leverage as execution and conversion progress into FY27.